These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 6636797

  • 1. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H.
    Wien Med Wochenschr; 1983 Aug 31; 133(15-16):403-8. PubMed ID: 6636797
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G, Poli F, Strinati R, Longo F.
    Pediatr Med Chir; 1984 Aug 31; 6(5):645-9. PubMed ID: 6535126
    [Abstract] [Full Text] [Related]

  • 5. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D, Molz KH, Staib AH, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 May 31; 19(5):223-7. PubMed ID: 7251238
    [Abstract] [Full Text] [Related]

  • 6. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S, Vrabec B, Francetić I, Bakran I.
    Lijec Vjesn; 1989 May 31; 111(9-10):341-3. PubMed ID: 2633012
    [Abstract] [Full Text] [Related]

  • 7. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
    McKenzie S, Baillie E.
    J Int Med Res; 1979 May 31; 7 Suppl 1():22-7. PubMed ID: 437305
    [Abstract] [Full Text] [Related]

  • 8. [Theophylline blood levels after administration of Euphyllin retard (author's transl)].
    Ahrens J.
    Dtsch Med Wochenschr; 1977 Apr 01; 102(13):482-6. PubMed ID: 844428
    [Abstract] [Full Text] [Related]

  • 9. [Comparative examination of theophylline-serum-concentrations and bronchospasmolytic effect of cholintheophyllinate (euspirax) and theophyllin-aethylendiamine (euphyllin retard) in patients with obstructive airway diseases (author's transl)].
    Wettengel R, Oellerich M, Schnitker J.
    Prax Klin Pneumol; 1979 Nov 01; 33(11):1125-31. PubMed ID: 523424
    [Abstract] [Full Text] [Related]

  • 10. [Comparative subacute study of the effects and side effects of a non-depot theophylline preparation (Euspirax) and a depot preparation (Euphyllin retard)--a contribution to long-term therapy of asthma].
    Eitner L, Wettengel R, Schnitker J.
    Prax Klin Pneumol; 1983 Jun 01; 37(6):236-42. PubMed ID: 6889277
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S, Raina RK, Samotra K, Gupta KL.
    Indian J Chest Dis Allied Sci; 1991 Jun 01; 33(1):1-8. PubMed ID: 1791015
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R.
    Wien Med Wochenschr; 1993 Jun 01; 143(2):37-42. PubMed ID: 8488685
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and bronchodilatory effect of proxyphylline and theophylline.
    Rasmussen FV, Waldorff S, Madsen L.
    Eur J Respir Dis; 1984 Jan 01; 65(1):20-7. PubMed ID: 6705854
    [Abstract] [Full Text] [Related]

  • 14. [Clinical use of theophylline retard Oranienburg].
    Slapke J, Hummel S, Wilke A, Wenz W, Meister W, Förster R, Wiesner B, Rentsch E, Nussbücker B.
    Z Erkr Atmungsorgane; 1988 Jan 01; 170(1):49-53. PubMed ID: 3291417
    [Abstract] [Full Text] [Related]

  • 15. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M, Fukutomi O, Kondo N, Kato Z, Nakashima Y, Shinoda S, Agata H, Kondo T, Imaeda N, Orii T.
    Int J Clin Pharmacol Ther; 1994 Nov 01; 32(11):625-31. PubMed ID: 7874380
    [Abstract] [Full Text] [Related]

  • 16. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
    Jenkins PF, White JP, Jariwalla AJ, Anderson G, Campbell IA.
    Br J Dis Chest; 1982 Jan 01; 76(1):57-60. PubMed ID: 7037034
    [Abstract] [Full Text] [Related]

  • 17. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM, Weinstein DB, Watts MT, Seifert B.
    Clin Ther; 1986 Jan 01; 8(2):175-80. PubMed ID: 3698064
    [Abstract] [Full Text] [Related]

  • 18. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H, Wilkens JH, Oellerich M, Sybrecht GW.
    Eur J Respir Dis; 1985 Mar 01; 66(3):196-204. PubMed ID: 3884358
    [Abstract] [Full Text] [Related]

  • 19. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
    Tsoĭ AN, Bogovskiĭ BP, Gavrilenko LN, Kushkenbaeva BE, Kukes VG.
    Ter Arkh; 1990 Mar 01; 62(9):22-5. PubMed ID: 2281401
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C, Niggemann B, Wahn U.
    Pneumologie; 1996 Nov 01; 50(11):752-5. PubMed ID: 9082442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.